Increased GABAergic transmission in neuropeptide Y-expressing neurons in the dopamine-depleted murine striatum.


Journal

Journal of neurophysiology
ISSN: 1522-1598
Titre abrégé: J Neurophysiol
Pays: United States
ID NLM: 0375404

Informations de publication

Date de publication:
01 04 2020
Historique:
pubmed: 12 3 2020
medline: 22 6 2021
entrez: 12 3 2020
Statut: ppublish

Résumé

As the main input nucleus of the basal ganglia, the striatum plays a central role in planning, control, and execution of movement and motor skill learning. More than 90% of striatal neurons, so-called medium spiny neurons (MSN), are GABAergic projection neurons, innervating primarily the substantia nigra pars reticulata or the globus pallidus internus. The remaining neurons are GABAergic and cholinergic interneurons, synchronizing and controlling striatal output by reciprocal connections with MSN. Besides prominent local cholinergic influence, striatal function is globally regulated by dopamine (DA) from the nigrostriatal pathway. Little is known about whether DA depletion, as occurs in Parkinson's disease, affects the activity of striatal interneurons. Here we focused on neuropeptide Y (NPY)-expressing interneurons, which are among the major subgroups of GABAergic interneurons in the striatum. We investigated the effects of striatal DA depletion on GABAergic transmission in NPY interneurons by electrophysiologically recording GABAergic spontaneous (s) and miniature (m) inhibitory postsynaptic currents (IPSCs) in identified NPY interneurons in slices from 6-hydroxydopamine (6-OHDA)- and vehicle-injected transgenic NPY-humanized

Identifiants

pubmed: 32159408
doi: 10.1152/jn.00059.2020
doi:

Substances chimiques

Adrenergic Agents 0
Neuropeptide Y 0
Oxidopamine 8HW4YBZ748
Dopamine VTD58H1Z2X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1496-1503

Auteurs

Lena Rubi (L)

University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland.

Jean-Marc Fritschy (JM)

University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland.
Neuroscience Center Zurich, Zurich, Switzerland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH